/People

Myla Lai-Goldman

Investor

Venture Partner at Hatteras Venture Partners

Burlington, Vermont

Writes $100K – $5M checks · typically $1.5M

Find your path to Myla

Sign up to see every warm intro you have to Myla

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Myla. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Myla Lai-Goldman is Chair and Co-Founder of GeneCentric Therapeutics, Inc. and serves as a Board Member at Mercy BioAnalytics, Inc. She spent over 18 years at LabCorp, including 10 years as Executive Vice President, Chief Medical Officer and Chief Scientific Officer, where she oversaw three genomic laboratories and led the introduction of more than 400 clinical assays. She holds a BS from the University of Pennsylvania and an MD from Columbia University College of Physicians and Surgeons, and is board-certified in anatomic and clinical pathology.

Contact· self-published, not guessed

Investments

Board seats

GeneCentric

Investor

Biocogniv

Sources: SEC Form D filings · curated public sources.

Colleagues at Hatteras Venture Partners

Frequently asked questions

Who is Myla Lai-Goldman?
Myla Lai-Goldman is Chair and Co-Founder of GeneCentric Therapeutics, Inc. and serves as a Board Member at Mercy BioAnalytics, Inc. She spent over 18 years at LabCorp, including 10 years as Executive Vice President, Chief Medical Officer and Chief Scientific Officer, where she oversaw three genomic laboratories and led the introduction of more than 400 clinical assays. She holds a BS from the University of Pennsylvania and an MD from Columbia University College of Physicians and Surgeons, and is board-certified in anatomic and clinical pathology.
Where does Myla Lai-Goldman work?
Myla Lai-Goldman is Venture Partner at Hatteras Venture Partners.
What check size does Myla Lai-Goldman write?
Myla Lai-Goldman typically writes checks of $100K – $5M.
What boards does Myla Lai-Goldman sit on?
Myla Lai-Goldman holds tracked board seats at GeneCentric.
What companies has Myla Lai-Goldman invested in?
Investments tracked here include Biocogniv.

Founder mafias

About this profile. Compiled from public sources — Hatteras Venture Partners's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights